ARTICLE | Clinical News
HTX-011: Phase II data
September 28, 2015 7:00 AM UTC
Top-line data from a double-blind, U.S. Phase II trial in 64 patients undergoing a bunionectomy showed that HTX-011 containing 400 mg bupivacaine met the primary endpoint of reducing SPI score over th...